MDBIF (TrivarX) Debt-to-Asset : 0.01 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is TrivarX Debt-to-Asset?

TrivarX's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.04 Mil. TrivarX's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. TrivarX's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $6.30 Mil. TrivarX's debt to asset for the quarter that ended in Dec. 2023 was 0.01.

TrivarX Debt-to-Asset Historical Data

The historical data trend for TrivarX's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Debt-to-Asset Chart

TrivarX Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Debt-to-Asset

Get a 7-Day Free Trial

0.01

TrivarX Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															0.01	-	0.01	0.01	-

Competitive Comparison of TrivarX's Debt-to-Asset

For the Health Information Services subindustry, TrivarX's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TrivarX's Debt-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where TrivarX's Debt-to-Asset falls into.

TrivarX Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

TrivarX's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.07	+	0)	/	5.391
	=	0.01

TrivarX's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.041	+	0)	/	6.297
	=	0.01

TrivarX (OTCPK:MDBIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

TrivarX Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of TrivarX's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

TrivarX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

TRI:Australia

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.trivarx.com

TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.